help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 26, 2007
Molecular Endocrinology, doi:10.1210/me.2006-0520
A more recent version of this article appeared on October 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
21/10/2320    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, D.
Right arrow Articles by Wang, D.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, D.
Right arrow Articles by Wang, D.-M.

Submitted on December 4, 2006
Accepted on June 20, 2007

CCPG, a Novel Constitutive Coactivator of PPAR{gamma} that Promotes Adipogenesis

Dechun Li*, Qiaohua Kang, and Dan-Ming Wang

Division of Pulmonary, Critical Care, and Sleep Medicine, Departments of Internal Medicineand Biochemistry and Molecular Biology, Saint Louis University, Saint Louis, MO

* To whom correspondence should be addressed. E-mail: dli2{at}slu.edu.

PPAR{gamma} plays essential roles in adipogenesis by transcriptionally regulating adipocyte-specific genes through recruitment of coregulators including coactivators and corepressors. However, the precise repertoire of coactivators required for PPAR{gamma} transactivation remains unresolved. In this report, we cloned and characterized a novel PPAR{gamma} interacting protein, Constitutive Coactivator of PPARgamma (CCPG), which is expressed in multiple adult tissues and throughout embryonic development. CCPG is localized in nucleus and contains four LXXLL motifs, which are characteristic for nuclear receptor coactivators. A delineation of CCPG-PPAR{gamma} interaction by GST-pull-down and co-immunoprecipitation assays indicated that CCPG interacts with the hinge region of PPAR{gamma} in a ligand-independent manner. However, mutation of four motifs of LXXLL to LXXAA in CCPG does not compromise its interaction with PPAR{gamma}, suggesting LXXLL motif is not required for the interaction. GST pull-down assays showed that CCPG binds to RXR{alpha} and ER{alpha} independent of their ligands, but not to TR{beta}. CCPG coactivates PPAR{gamma} in PPRE reporter assays and the N-terminus (amino acids 1-561) of CCPG acts to significantly augment the transactivation of PPAR{gamma}, while the C-terminus (amino acids 562-786) represses PPAR{gamma} activity indicating the N-terminus possesses the activation domain. Using adenoviral mediated system, we also revealed that overexpression of CCPG promoted differentiation of OP9 preadipocyte into adipocyte, and knockdown of CCPG by RNAi blocked this process, as examined by Oil-Red-O staining and western blots of adipocyte-specific protein adiponectin and perilipin. Taken together, our data indicate that CCPG is a bona fide coactivator and promotes adipogenesis in a PPAR{gamma} dependent manner.


Key words: nuclear receptors • PPAR{gamma} • adipogenesis • coactivators • preadipocyte







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society